As the COVID-19 pandemic rages on, the LAist reports that the mental health of frontline workers, such as health care workers and first responders, may be in jeopardy. The article cites Dr. Joshua Morganstein who alludes to possible “psychological disorders, like depression and anxiety and post-traumatic stress disorder.”
KARE-TV 11 in Minneapolis-St. Paul reported that police brutality of unarmed Black Americans affects the mental health of Black Americans as a whole. Research published 2 years ago shows trauma is an illness that can negatively impact mental health. In this case, police killings negatively affected the mental state of Black adults. Alexander Tsai, a psychiatrist at Massachusetts General Hospital and professor of psychiatry at Harvard Medical School, said that the trauma can manifest as “depression, anxiety or irritability” in adults.
WJLA-TV/ABC7 interviewed Dr. Alban Gaultier, an associate professor of neuroscience at the University of Virginia, about the potential for an antidepressant drug, fluvoxamine, to be used in the fight against COVID-19. The drug shows promise by “preventing[ing] dangerous overreactions by the immune system” induced by COVID-19. A clinical trial is currently underway at the Washington University School of Medicine in St. Louis, Missouri. A possible answer could emerge as soon as 2 months from now.